omre US
omre US
Skip to main content
MADE IN THE USA
FREE US SHIPPING OVER $80
HSA/FSA ELIGIBLE
Shop Learn Bundle & Save
Cart (0)

NAD Precursors: What They Are and How They Support NAD+ Production

Updated on Aug 30, 2026
NAD Precursors: What They Are and How They Support NAD+ Production
Medically reviewed by Dr. Sara Alisha Khan, MD, PGDMLE— Written by Dr. Sara Alisha Khan, MD, PGDMLE
Updated on Aug 30, 2026

Table of contents

An NAD precursor is a compound your body can use to make NAD+, a molecule involved in cellular energy production, metabolism, DNA-related processes, and cell signaling. NMN and NR get most of the attention today, but they are not the only NAD precursors. Nicotinamide, nicotinic acid, and even the amino acid tryptophan can feed into NAD+ production through different pathways. (1)

Interest in these compounds has grown alongside research into NAD+ and aging. There is one important catch, though. 

Human trials show that certain NAD precursors can raise NAD+ or related metabolites in the blood, but we do not yet have evidence that taking one extends human lifespan. (2)

Key Takeaways:

  • NMN, NR, nicotinamide, nicotinic acid, and tryptophan can all contribute to NAD+ production.

  • NMN and NR are the two NAD precursors getting the most attention in healthy aging research.

  • Human trials show that both NMN and NR can increase NAD-related biomarkers. (2)(3)

  • Raising NAD+ in a blood test does not prove that a supplement slows aging or extends lifespan. (4)

What Is an NAD Precursor?

Think of NAD+ production as a manufacturing line. Your body needs starting materials, enzymes, and several conversion steps before it gets the finished molecule.

Those starting materials are NAD precursors.

Researchers generally recognize five major precursors or intermediates involved in NAD+ synthesis: tryptophan, nicotinic acid, nicotinamide, nicotinamide riboside (NR), and nicotinamide mononucleotide (NMN). (1)

They do not all travel down the same route.

Your body uses three main NAD+ production pathways:

  • De novo pathway: starts with the amino acid tryptophan

  • Preiss-Handler pathway: uses nicotinic acid, a form of vitamin B3

  • Salvage pathway: recycles nicotinamide and uses compounds such as NR and NMN

The salvage pathway matters a lot because NAD+ does not simply sit around once your cells make it. Enzymes continually use NAD+, creating nicotinamide that the body can recycle back toward NAD+ again. (1)

So, calling something an NAD precursor simply means it can enter this production and recycling system. It does not tell us how powerful a supplement is or what health effect it will have.

What Are the Main NAD+ Precursors?

NMN and NR have become the headline acts, but the NAD+ pathway has a larger cast.

NMN

Nicotinamide mononucleotide, or NMN, is a direct precursor used to make NAD+.

Inside the pathway, an enzyme called NMNAT converts NMN into NAD+. NMN can also be produced naturally in the body from nicotinamide and NR. (1)

This short route is one reason NMN gets so much attention in longevity research.

Human evidence has grown in the last several years. In one randomized trial involving 80 healthy middle-aged adults, participants received 300, 600, or 900 mg of NMN daily for 60 days. Blood NAD concentrations rose significantly in all three NMN groups, with the highest concentrations seen in the 600 and 900 mg groups. (3)

That tells us something useful: oral NMN can affect NAD metabolism in humans.

It does not tell us that NMN makes someone live longer. That distinction matters.

NR

Nicotinamide riboside, or NR, is another vitamin B3-related NAD precursor.

NR is converted into NMN by nicotinamide riboside kinases. NMN can then be converted into NAD+. (1)

NR has been studied in humans for longer than NMN.

One randomized trial followed 132 healthy adults who were overweight and received placebo or 100, 300, or 1,000 mg of NR each day for eight weeks. After 14 days, whole-blood NAD+ had risen by about 22% in the 100 mg group, 51% in the 300 mg group, and 142% in the 1,000 mg group compared with baseline. The increases remained largely sustained through day 56. (2)

Those numbers make NR's effect on blood NAD+ fairly easy to see.

What happens downstream is less clear. A larger NAD+ number does not automatically translate into better energy, better cognition, slower aging, or longer life.

Nicotinamide

Nicotinamide, also called niacinamide or NAM, is another form of vitamin B3.

It is especially interesting because your body does not just consume it from food. Nicotinamide also appears when NAD+ gets used by cellular enzymes. The body can then recycle that nicotinamide back toward NAD+ through the salvage pathway. (1)

The process goes roughly like this:

Nicotinamide → NMN → NAD+

NMN is therefore not an isolated compound appearing out of nowhere. It sits inside a recycling system your cells already use every day.

Nicotinic Acid

Nicotinic acid is the form of vitamin B3 many people simply know as niacin.

It can also become NAD+, although it enters through the Preiss-Handler pathway instead of following the same route as NMN and NR. (1)

At higher supplemental doses, nicotinic acid can cause the well-known "niacin flush," which may include warmth, redness, itching, or tingling of the skin.

That is one practical reason newer compounds such as NR and NMN receive so much attention despite niacin having a much longer history in human nutrition.

Tryptophan

Here is the precursor people rarely hear about in NAD supplement conversations.

Tryptophan can also serve as a starting material for NAD+ production. (1)

Yes, the same essential amino acid found in protein-rich foods.

The pathway is far longer, though. Your body converts tryptophan through the kynurenine pathway before eventually reaching NAD+. That makes tryptophan quite different from taking something much further downstream, such as NMN.

This is also why saying that NMN is the NAD precursor is inaccurate. It is one of several.

NMN vs NR: Which NAD Precursor Is Better?

There is not enough head-to-head human evidence to say that NMN or NR is the better NAD precursor for everyone.

Both can influence NAD+ metabolism in humans. The problem is that the studies use different populations, doses, measurements, and trial lengths, so comparing results across separate studies can give a false sense of precision.

Here is the simpler comparison:

NMN NR
Full name Nicotinamide mononucleotide Nicotinamide riboside
Relationship to NAD+ Direct NAD+ precursor Converts to NMN on the pathway to NAD+
Human studies available Yes Yes
Has increased NAD-related biomarkers in trials? Yes Yes
Proven to slow human aging? No No
Proven to extend human lifespan? No No

You may hear that NMN must work better because it sits one metabolic step closer to NAD+.

Biochemistry is not quite that tidy.

What you swallow still has to move through the digestive system, interact with gut microbes and enzymes, enter circulation, reach tissues, and undergo further metabolism. A shorter pathway on paper does not prove greater clinical benefit.

Until researchers run strong direct comparisons, declaring a universal winner gets ahead of the evidence.

What Does Human Research on NAD Precursors Show?

This is where NAD research gets interesting, and a little messy.

We have good evidence that some precursors are biologically active in humans. We have much less certainty around the larger longevity claims attached to them.

Take NR first. As noted above, researchers gave 132 adults 100, 300, or 1,000 mg of NR daily. After two weeks, whole-blood NAD+ rose roughly 22%, 51%, and 142%, respectively. (2)

NMN has produced similar evidence of biological activity.

In the 80-person trial using 300, 600, and 900 mg per day, blood NAD concentrations increased across every NMN dose after 30 and 60 days. 

Participants taking NMN also improved their six-minute walking distance more than the placebo group, although this was a short study and should not be treated as proof of a lasting physical-performance benefit. (3)

Another small randomized trial looked at something more specific.

Twenty-five postmenopausal women with prediabetes who were overweight or obese received either placebo or 250 mg of NMN daily for 10 weeks. 

NMN increased skeletal muscle insulin sensitivity by about 25%, while several other measures, including body composition and some metabolic outcomes, did not show the same improvement. (5)

That last detail is important. Real clinical studies rarely give us a neat "everything improved" result. Some markers change. Others do not.

That is far more useful than simply saying NAD precursors "support healthy aging."

Blood NAD+ Is a Biomarker, Not a Lifespan Test

Here is one of the easiest mistakes to make when reading NAD supplement research:

Higher NAD+ does not equal proven anti-aging.

If someone's blood NAD+ increases after taking NMN or NR, the supplement clearly interacted with NAD metabolism. That is meaningful.

But researchers still have to answer a different question: does changing that biomarker produce a meaningful improvement in health?

A 2025 review in Nature Metabolism examined human NAD+ research and found that clinical benefits from NAD precursor supplementation remain limited compared with the much stronger findings seen in animal research. The authors also noted that human tissue data remain sparse. (4)

That is why claims such as "raises NAD+" and "slows aging" should never be treated as interchangeable.

Do NAD+ Levels Decline With Age?

You may have seen claims that NAD+ drops by a fixed percentage once you hit 40, 50, or 60.

The human evidence is not that precise.

Laboratory and animal research has linked aging with disrupted NAD+ metabolism. Some human studies have also found lower NAD+ levels with age.

Still, the 2025 Nature Metabolism review found that a consistent age-related decline in NAD+ has only been demonstrated in a limited number of human studies. Different tissues may behave differently, and researchers do not yet have a complete map of how NAD+ changes across the human body as we age. (4)

So, "NAD+ may decline with age" is reasonable.

"NAD+ falls by X% after age 40" is much harder to defend without specifying exactly which tissue, population, and study produced that number.

It is a small wording difference, but scientifically, it is a big one.

Can You Get NAD Precursors From Food?

Yes. NAD+ metabolism starts long before supplements enter the picture.

Your diet provides several raw materials your body can use to maintain NAD+ production.

Examples include:

  • Meat

  • Fish

  • Eggs

  • Dairy foods

  • Whole grains

  • Nuts and seeds

  • Legumes

  • Foods containing tryptophan

  • Foods providing vitamin B3

Tiny amounts of NMN and NR can also occur naturally in certain foods. (1)

There is an important dose difference, though.

The clinical trials discussed above used hundreds of milligrams of isolated NMN or NR per day. Food amounts are much smaller, so eating NMN-containing vegetables cannot be treated as nutritionally equivalent to taking a 300 or 600 mg NMN supplement.

That does not make supplements "better" than food. They are simply different exposures.

A balanced diet still supplies the vitamins, amino acids, minerals, fats, and other nutrients your cells need to run the wider metabolic machinery around NAD+.

Who Might Consider an NAD Precursor Supplement?

NAD precursors tend to attract people interested in healthy aging, cellular metabolism, and maintaining function as they get older.

At the same time, the human research is still developing. That makes it sensible to approach them as supplements with emerging evidence rather than proven anti-aging treatments.

Before taking one, speak with a qualified healthcare professional if you:

  • Are pregnant or breastfeeding

  • Take prescription medications

  • Have a diagnosed medical condition

  • Are receiving cancer treatment

  • Plan to take a high dose

  • Experience unexplained symptoms that you are trying to treat with supplements

Supplements should not replace treatment for a diagnosed condition.

How to Choose an NAD Precursor Supplement

If you decide to try one, the front of the bottle tells you very little. Look deeper.

A good product should make it easy to find:

  • The exact NAD precursor being used

  • The amount per serving

  • A clear ingredient list

  • Third-party testing information

  • Manufacturing quality standards

  • Testing for contaminants and purity

  • Realistic claims that match current human research

Be skeptical of products promising to "reverse aging," dramatically extend lifespan, or make your cells biologically young again.

Those claims run several laps ahead of human evidence.

Final Words

NAD precursors are not magic molecules, but they are biologically interesting. Your body can make NAD+ from several starting materials, including tryptophan, nicotinic acid, nicotinamide, NR, and NMN. Among supplemental forms, NMN and NR now have human trials showing measurable effects on NAD-related biomarkers. (1)(2)(3)

The next question is harder: does raising NAD+ translate into meaningful long-term health benefits?

Researchers are still working that out. Short human trials have produced some promising findings, including changes in insulin sensitivity and physical-performance measures, yet we do not have evidence that an NAD precursor extends human lifespan. (3)(4)(5)

At Omre, we use NMN in our NMN + Resveratrol formula for people looking for a research-led way to support NAD+ production and healthy aging. We still think the science should set the boundaries of the claim, not the marketing department.

FAQs

What is the best precursor to NAD+?

There is no proven best NAD precursor for everyone. NMN and NR can both increase NAD-related biomarkers in human studies, but researchers have not established one as clearly superior for healthy aging. (2)(3)

Is NMN an NAD precursor?

Yes. NMN is a direct precursor your cells can convert into NAD+ using NMN adenylyltransferase enzymes. (1)

Is NR better than NMN for increasing NAD+?

We do not have enough direct head-to-head human research to say NR is better than NMN, or vice versa. Both have increased NAD-related biomarkers in clinical studies. (2)(3)

Is vitamin B3 an NAD precursor?

Yes. Both nicotinic acid and nicotinamide, two forms associated with vitamin B3, can contribute to NAD+ production through different pathways. (1)

Can NAD precursors slow aging?

No human trial has shown that taking NMN, NR, or another NAD precursor slows biological aging enough to prove longer lifespan. Research has found changes in NAD-related biomarkers and some health measures, but clinical evidence for broad anti-aging effects remains limited. (4)

References

1. Katsyuba E, et al. Current Uncertainties and Future Challenges Regarding NAD+ Boosting Strategies. This review explains how tryptophan, nicotinic acid, nicotinamide, NMN, and NR feed into different NAD+ synthesis pathways. Read the NAD+ precursor pathway review on PubMed Central.

2. Conze D, et al. Safety and Metabolism of Long-term Administration of NIAGEN in a Randomized, Double-Blind, Placebo-controlled Clinical Trial of Healthy Overweight Adults. The eight-week trial reported dose-related increases in whole-blood NAD+ following NR supplementation. Read the NR clinical trial on PubMed Central.

3. Yi L, et al. The efficacy and safety of β-nicotinamide mononucleotide supplementation in healthy middle-aged adults. This randomized trial compared 300, 600, and 900 mg daily NMN doses over 60 days. View the NMN dose-ranging study on PubMed.

4. Vinten KT, et al. NAD+ precursor supplementation in human ageing: clinical evidence and challenges. This 2025 review examines human evidence for age-related NAD+ changes and the clinical effects of NAD precursor supplementation. Read the clinical evidence review on PubMed.

5. Yoshino M, et al. Nicotinamide mononucleotide increases muscle insulin sensitivity in prediabetic women. In this randomized trial, 250 mg of NMN daily for 10 weeks increased skeletal muscle insulin sensitivity in postmenopausal women with prediabetes. Read the NMN insulin-sensitivity study on PubMed Central.

About the medical reviewer

Dr. Sara Alisha Khan, MD, PGDMLE

Sara Alisha Khan, MD is a physician and medical reviewer with experience in clinical care, telemedicine, and medical AI. She is currently a Project Consultant at AIIMS (All India Institute of Medical Sciences), New Delhi, and has supported medical AI diagnostic projects, including fetal ultrasound imaging. At OMRE, she reviews health content for clinical accuracy, safety, and evidence alignment. She currently works for Omre as an advisor.

Medically reviewed by
Dr. Sara Alisha Khan, MD, PGDMLE

Sara Alisha Khan, MD is a physician and medical reviewer with experience in clinical care, telemedicine, and medical AI. She is currently a Project Consultant at AIIMS (All India Institute of Medical Sciences), New Delhi, and has supported medical AI diagnostic projects, including fetal ultrasound imaging. At OMRE, she reviews health content for clinical accuracy, safety, and evidence alignment. She currently works for Omre as an advisor.

Table of contents

Share

Related Blog Posts

Read all articles